KELLY HAUSENBAUER: Open Payments
NPI 1053695304 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,026 in 125 payments from 19 companies in 2025. Trend: 2023 $816 · 2024 $1,977 · 2025 $3,026
Food & beverage: $2,949Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $413 |
| Janssen Biotech, Inc. | 10 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $293 |
| Gilead Sciences, Inc. | 9 | $252 |
| Ipsen Biopharmaceuticals, Inc | 8 | $214 |
| Madrigal Pharmaceuticals | 10 | $196 |
| Phathom Pharmaceuticals, Inc. | 7 | $182 |
| Regeneron Healthcare Solutions, Inc. | 10 | $166 |
| PFIZER INC. | 8 | $162 |
| Ardelyx, Inc. | 5 | $158 |
Products named: TREMFYA, DUPIXENT, ENTYVIO, RINVOQ, IQIRVO, REZDIFFRA, VOQUEZNA, IBSRELA.
Industry payments across MD — which companies pay providers there.
